A Real-world Study of Adjuvant Therapy in Early Stage NSCLC With EGFR Mutation-Positive in China
Clinical trial NCT04830826 · COMPLETED
Trial details
- NCT number
- NCT04830826
- Sponsor
- The First Affiliated Hospital of Guangzhou Medical University
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-07-09
- Primary completion
- 2024-07-08
- Enrollment
- 1490
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.